Stay updated on KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Sign up to get notified when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.
Latest website image capture
Clouds background image

Latest updates to the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    A banner announcing NIH website-transition updates and the temporary use of “Super Intelligence” alongside “Artificial Intelligence” was removed.
    Difference
    1%
    Check dated 2026-11-08T02:26:26.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T22:26:46.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:26:26.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T22:28:01.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov release label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:20:32.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The content now presents a 403 Forbidden error page, replacing the study details with a standard error view. The header and surrounding footer indicate a blocked access state rather than the searchable study information.
    Difference
    19%
    Check dated 2026-09-19T21:01:31.000Z thumbnail image

Stay in the know with updates to KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Enter your email address, and we'll notify you when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.